Stay updated on Concizumab Clinical Trial in Haemophilia with Inhibitors
Sign up to get notified when there's something new on the Concizumab Clinical Trial in Haemophilia with Inhibitors page.

Latest updates to the Concizumab Clinical Trial in Haemophilia with Inhibitors page
- Check4 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, indicating access is blocked. This change reflects an error state rather than a substantive update to the page.SummaryDifference19%

- Check11 days agoChange DetectedTel Litwinsky, Israel has been added to the list of study locations, and Qiryat Krinitzi, Israel has been removed from the locations.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe study locations list updates to replace Tel Litwinsky, Israel, 52621 with Qiryat Krinitzi, Israel, 52621. Additionally, the revision tag was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check32 days agoChange DetectedAdds 2016 ( U.S. NIH Grant/Contract ) to the study's Other Study ID Numbers to reflect NIH funding information.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision badge updated from v3.6.4 to v3.6.5, indicating a minor internal update to the page's versioning.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision label was updated to v3.6.4, replacing the previous v3.6.3.SummaryDifference0.0%

Stay in the know with updates to Concizumab Clinical Trial in Haemophilia with Inhibitors
Enter your email address, and we'll notify you when there's something new on the Concizumab Clinical Trial in Haemophilia with Inhibitors page.